83 related articles for article (PubMed ID: 21672525)
21. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J
Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population.
Hu Z; Xu L; Shao M; Yuan J; Wang Y; Wang F; Yuan W; Qian J; Ma H; Wang Y; Liu H; Chen W; Yang L; Jing G; Huo X; Chen F; Jin L; Wei Q; Wu T; Lu D; Huang W; Shen H
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1336-40. PubMed ID: 16835333
[TBL] [Abstract][Full Text] [Related]
24. Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts.
Maes OC; Sarojini H; Wang E
J Cell Physiol; 2009 Oct; 221(1):109-19. PubMed ID: 19475566
[TBL] [Abstract][Full Text] [Related]
25. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
26. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
[TBL] [Abstract][Full Text] [Related]
27. Nucleotide excision repair is a potential therapeutic target in multiple myeloma.
Szalat R; Samur MK; Fulciniti M; Lopez M; Nanjappa P; Cleynen A; Wen K; Kumar S; Perini T; Calkins AS; Reznichenko E; Chauhan D; Tai YT; Shammas MA; Anderson KC; Fermand JP; Arnulf B; Avet-Loiseau H; Lazaro JB; Munshi NC
Leukemia; 2018 Jan; 32(1):111-119. PubMed ID: 28588253
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
[TBL] [Abstract][Full Text] [Related]
29. [Cloning and identification of microRNA from human osteosarcoma cell line SOSP-9607].
Gao J; Yang TT; Qiu XC; Yu B; Han JW; Fan QY; Ma BA
Ai Zheng; 2007 Jun; 26(6):561-5. PubMed ID: 17562257
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA regulation of DNA repair gene expression in hypoxic stress.
Crosby ME; Kulshreshtha R; Ivan M; Glazer PM
Cancer Res; 2009 Feb; 69(3):1221-9. PubMed ID: 19141645
[TBL] [Abstract][Full Text] [Related]
31. Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line.
Liu Y; Zhao JJ; Wang CM; Li MY; Han P; Wang L; Cheng YQ; Zoulim F; Ma X; Xu DP
Chin Med J (Engl); 2009 Jan; 122(1):10-4. PubMed ID: 19187610
[TBL] [Abstract][Full Text] [Related]
32. Deficiency in nucleotide excision repair family gene activity, especially ERCC3, is associated with non-pigmented hair fiber growth.
Yu M; Bell RH; Ho MM; Leung G; Haegert A; Carr N; Shapiro J; McElwee KJ
PLoS One; 2012; 7(5):e34185. PubMed ID: 22615732
[TBL] [Abstract][Full Text] [Related]
33. Characterization of illudin S sensitivity in DNA repair-deficient Chinese hamster cells. Unusually high sensitivity of ERCC2 and ERCC3 DNA helicase-deficient mutants in comparison to other chemotherapeutic agents.
Kelner MJ; McMorris TC; Estes L; Rutherford M; Montoya M; Goldstein J; Samson K; Starr R; Taetle R
Biochem Pharmacol; 1994 Jul; 48(2):403-9. PubMed ID: 8053936
[TBL] [Abstract][Full Text] [Related]
34. Functional profiling of nucleotide Excision repair in breast cancer.
Rajkumar-Calkins AS; Szalat R; Dreze M; Khan I; Frazier Z; Reznichenkov E; Schnorenberg MR; Tsai YF; Nguyen H; Kochupurakkal B; D'Andrea AD; Shapiro GI; Lazaro JB; Mouw KW
DNA Repair (Amst); 2019 Oct; 82():102697. PubMed ID: 31499327
[TBL] [Abstract][Full Text] [Related]
35. A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.
Vijai J; Topka S; Villano D; Ravichandran V; Maxwell KN; Maria A; Thomas T; Gaddam P; Lincoln A; Kazzaz S; Wenz B; Carmi S; Schrader KA; Hart SN; Lipkin SM; Neuhausen SL; Walsh MF; Zhang L; Lejbkowicz F; Rennert H; Stadler ZK; Robson M; Weitzel JN; Domchek S; Daly MJ; Couch FJ; Nathanson KL; Norton L; Rennert G; Offit K
Cancer Discov; 2016 Nov; 6(11):1267-1275. PubMed ID: 27655433
[TBL] [Abstract][Full Text] [Related]
36. ERCC4: a potential regulatory factor in inflammatory bowel disease and inflammation-associated colorectal cancer.
Shi R; Wang S; Jiang Y; Zhong G; Li M; Sun Y
Front Endocrinol (Lausanne); 2024; 15():1348216. PubMed ID: 38516408
[TBL] [Abstract][Full Text] [Related]
37. On the absence of mutations in nucleotide excision repair genes in sporadic solid tumors.
Mombach JC; Castro MA; Moreira JC; de Almeida RM
Genet Mol Res; 2008 Feb; 7(1):152-60. PubMed ID: 18393219
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs in mutagenesis, genomic instability, and DNA repair.
Landau DA; Slack FJ
Semin Oncol; 2011 Dec; 38(6):743-51. PubMed ID: 22082760
[TBL] [Abstract][Full Text] [Related]
39. miRNA dysregulation is an emerging modulator of genomic instability.
Ferragut Cardoso AP; Banerjee M; Nail AN; Lykoudi A; States JC
Semin Cancer Biol; 2021 Nov; 76():120-131. PubMed ID: 33979676
[TBL] [Abstract][Full Text] [Related]
40. Attenuated nucleotide excision repair leads to mutagenesis in cancer cells.
Nouspikel T
Future Oncol; 2011 Dec; 7(12):1361-3. PubMed ID: 22112311
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
